Des Jarlais
Don C. Des Jarlais, PhD
CDUHR - Associate Director, Infectious Disease Epidemiology and Social-behavioral Theory Core
NYU School of Global Public Health - Professor
PhD, Social Psychology, University of Michigan, Ann Arbor
BA, Behavioral Science, Rice University
Research Interests
Injecting drug use, Epidemiology, HIV, HCV, Research synthesis
For over 30 years Don Des Jarlais has been conducting HIV/AIDS research among persons who inject drugs (PWID). He is PI of the “Risk Factors” study (R01DA003574), which was instrumental in tracking the HIV/AIDS epidemic in New York City. This study has been funded by the National Institute on Drug Abuse since 1983 and is the longest continuously funded study on HIV/AIDS in persons who use drugs. He has conducted HIV/AIDS research nationally (Seattle, CDC CIDUS studies, national syringe exchange survey) and internationally (in over 20 different countries). He has served as a consultant on these issues to the World Health Organization, the National Institutes of Health and the U.S. Centers for Disease Control and Prevention.
Principal Investigator, Combined Prevention to Reduce Initiation Into Injecting Drug Use. Active
Principal Investigator, DRIVE (Drug Use and Blood-Borne Infections in Vietnam): Combined Prevention and Care to End the HIV Epidemic Among People Who Inject Drugs in Haiphong, Vietnam. Active
Principal Investigator, Risk Factors for AIDS among Drug Users: Getting Close to Zero. Active
Principal Investigator, Barriers to Reason: Laws Impacting HIV Prevention Efforts among IDUs in the United States. Completed
Principal Investigator, Combined HIV Prevention for PWID and Future Collaborative Research in Vietnam. Completed
Principal Investigator, Evaluating ART for All HIV Seropositives: Can It Work with the Hardest Cases?. Completed
Principal Investigator, Expanded Syringe Access Program: NY Evaluation (ESAP). Completed
Principal Investigator, HIV Infection in Ethnic Minority IDUs: An International Systematic Review. Completed
Principal Investigator, HIV Transmission among Injecting and Non-Injecting Drug Users in Tallinn, Estonia. Completed
Principal Investigator, Multiple HIV Prevention Packages for IDUs in Estonia. Completed
Principal Investigator, National Study of Syringe Exchange Programs. Completed
Principal Investigator, WHO Survey Coordinating Center, Drug Injecting Study – Phase 2. Completed


Uuskula A, Talu A, Rannap J, Barnes DM, Des Jarlais D (2021).
Rapid point-of-care (POC) testing for hepatitis C antibodies in a very high prevalence setting: Persons injecting drugs in Tallinn, Estonia
Harm Reduction Journal, 18 (1), 39. doi: 10.1186/s12954-021-00485-5. PMCID: PMC8015736.

Wise A, Kianian B, Chang H, Linton S, Wolfe ME, Smith J, Tempalski B, Des Jarlais D, Ross Z, Semaan S, Wejnert C, Broz D, Cooper H (2021).
Place-based correlates of exchange sex among people who inject drugs in 19 U.S. metropolitan areas, 2012
Archives of Sexual Behavior [Epub 2021 Apr 1]. doi: 10.1007/s10508-020-01883-9.

Des Jarlais DC, Arasteh K, Barnes DM, Feelemyer J, Berg H, Raag M, Talu A, Org G, Tross S, Uuskula A (2021).
A multistage process model of how a person who currently injects drugs comes to assist persons who do not inject with their first injections
Frontiers in Sociology, 6, 619560. doi: 10.3389/fsoc.2021.619560. PMCID: PMC8022482.

Bennett AS, Freeman R, Des Jarlais DC, Aronson ID (2020).
Reasons people who use opioids do not accept or carry no-cost naloxone: Qualitative interview study
JMIR Formative Research, 4 (12), e22411. doi: 10.2196/22411. PMCID: PMC7787889.

Des Jarlais DC, Huong DT, Oanh KTH, Feelemyer JP, Arasteh K, Khue PM, Giang HT, Thanh NTT, Vinh VH, Le SM, Vallo R, Quillet C, Rapoud D, Michel L, Laureillard D, Moles JP, Nagot N (2020).
Ending an HIV epidemic among persons who inject drugs in a middle-income country: Extremely low HIV incidence among persons who inject drugs in Hai Phong, Viet Nam
AIDS, 34 (15), 2305-2311. doi: 10.1097/QAD.0000000000002712.


Des Jarlais DC, Huong DT (2018).
Ending HIV epidemics among people who inject drugs in LMICs
Lancet, 392 (10149), 714-719. doi: 10.1016/S0140-6736(18)31721-5.

Dr. Des Jarlais' ResearchGate Profile
Selected Press